Background: We previously demonstrated the clinical utility of using response to therapy
variables obtained during the first 2 years of follow-up to actively modify initial risk estimates …

Objectives: The aims of this study were to validate the proposed Latin American Thyroid
Society (LATS) risk of recurrence stratification system and to compare the findings with those …

Objective To validate the A merican T hyroid A ssociation (ATA) initial risk of recurrence
scheme and the M emorial S loan K ettering C ancer C enter (MSKCC) response to therapy …

Objective: The primary purpose of this study was to validate the proposed modified 2009
American Thyroid Association Risk Stratification System (M-2009-RSS) in patients with …

Background: Current management guidelines suggest that 6–12 months after total
thyroidectomy and radioactive iodine remnant ablation (RAI-RA), patients with differentiated …

Purpose To compare disease-specific survival and recurrence-free survival (RFS) after
successful 131 I ablation in patients with differentiated thyroid carcinoma (DTC) between …

Context Despite its good prognosis, differentiated thyroid cancer (DTC) is characterized by
high rates of disease persistence and recurrence. Estimation of long-term remission …

Purpose The aim of this study was to assess the prognostic factors for treatment efficacy, and
in particular the increase in serum thyroglobulin (Tg) level at the time of the first ablative …

Context: Although response to therapy assessment is a validated tool for dynamic risk
stratification in patients with differentiated thyroid cancer (DTC) treated with total …

Objective Whether the initiating time of radioiodine (RAI) therapy will affect the clinical
outcome in differentiated thyroid cancer (DTC) remains controversial. The objective of this …